BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3502478)

  • 1. Effect of corticosteroid on passively transferred experimental allergic neuritis.
    Ota K; Tanaka H; Nakayasu H; Irie H; Takahashi K
    Jpn J Exp Med; 1987 Dec; 57(6):299-303. PubMed ID: 3502478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM; Pollard JD
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin A.
    Nakayasu H; Ota K; Tanaka H; Irie H; Takahashi K
    J Neuroimmunol; 1990 Mar; 26(3):219-27. PubMed ID: 1689744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides improve the outcome of experimental allergic neuritis (EAN).
    Oderfeld-Nowak B; Brosnan C; Cervone A; Oderfeld J; Ledeen RW
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):495-504. PubMed ID: 2130664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rats with experimental allergic neuritis using high dose immunoglobulin.
    Jia J; Jia J; Pollock M
    Chin Med J (Engl); 2000 Dec; 113(12):1096-9. PubMed ID: 11776144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis.
    Hahn AF; Feasby TE; Wilkie L; Lovgren D
    Muscle Nerve; 1993 Nov; 16(11):1174-80. PubMed ID: 7692294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of experimental autoimmune neuritis by IL-12 and IL-18 synergistically potentiated lymphoid cells is regulated by NKR-P1+ cells.
    Sun B; Li HL; Wang JH; Wang GY; Zhao R; Mu LL; Jin LH
    Scand J Immunol; 2007 May; 65(5):412-20. PubMed ID: 17444951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
    Zhang Z; Zhang ZY; Schluesener HJ
    J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
    Yun W; Hua-bing W; Wei-zhi W
    J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The passive transfer of severe allergic neuritis in Lewis rats with lymphoid cells preincubated with P2 protein.
    Szymanska I; Ramwani J; Eylar EH
    Cell Immunol; 1983 Dec; 82(2):422-5. PubMed ID: 6197195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
    Pilartz M; Jess T; Indefrei D; Schröder JM
    Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
    Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
    Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
    Araga S; Kishimoto M; Doi S; Nakashima K
    J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
    Tan XD; Dou YC; Shi CW; Duan RS; Sun RP
    J Neuroimmunol; 2009 Feb; 207(1-2):39-44. PubMed ID: 19174309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.